Evidence map›Paper›PMID 18452257›Full record

ArticleYonsei medical journal2008

The effect of lowering the threshold for diagnosis of impaired fasting glucose.

So Hun Kim, Wan Sub Shim, Eun A Kim, Eun Joo Kim, Seung Hee Lee, Seong Bin Hong, Yong Seong Kim, Shin Goo Park, Jong Han Leem, Jong Whan Lim and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Yonsei medical journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

  • Erratum issued
    Lim, Jong Whan [corrected to Leem, Jong Han]
5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

So Hun KimDepartment of Internal Medicine, Inha University College of Medicine, 7-206 3-ga, Shinhung-dong, Jung-gu, Incheon 400-711, Korea.
Wan Sub Shim
Eun A Kim
Eun Joo Kim
Seung Hee Lee
Seong Bin Hong
Yong Seong Kim
Shin Goo Park
Jong Han Leem
Jong Whan Lim
Hun-Jae Lee
Moonsuk Nam
Inha University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to evaluate the effect of lowering the fasting plasma glucose (FPG) criteria for impaired fasting glucose (IFG) on the prevalence of IFG and the risk for the development of diabetes associated with IFG in Koreans. MATERIALS AND

methodsA total of 7,211 subjects who had normal glucose tolerance (NGT) or IFG were recruited. Subjects were evaluated at baseline and after two years follow up. Clinical data including total cholesterol, FPG and blood pressure were examined.

resultsLowering the criteria for IFG from 6.1 mmol/L (110 mg/dL) to 5.6 mmol/L (100 mg/dL) increased the prevalence of IFG from 6.6% (494 subjects) to 24.4% (1829 subjects). After the 2 years follow up period, 91 subjects (1.3%) developed diabetes. Twenty one (0.3%) subjects developed diabetes among 5,382 NGT subjects and 70 (3.8%) subjects developed diabetes among 1,829 IFG (5.6-7.0 mmol/L) subjects. Lowering the IFG threshold from 6.1 mmol/L to 5.6 mmol/L resulted in a 18.4% decrease in specificity and 23.9% increase in sensitivity for predicting diabetes. The baseline FPG for predicting the development of diabetes after 2 years at a point on the receiver operating characteristic curve that was closest to the ideal 100% sensitivity and 100% specificity was 5.7 mmol/L (103 mg/dL).

conclusionLowering the FPG criterion of IFG should have benefits in predicting new onset type 2 diabetes mellitus in Koreans. The economic and health benefits of applying the new IFG criteria should be evaluated in future studies.

Indexed as

AdultAsian PeopleBlood GlucoseDiabetes Mellitus, Type 2FastingFemaleGlucose Tolerance TestHumansMaleMiddle AgedBlood Glucose

Identifiers

PMID18452257
PMCPMC2615324
OpenAlexW2162718053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.